Matches in Wikidata for { <http://www.wikidata.org/entity/Q76340017> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q76340017 description "article scientifique publié en 2004" @default.
- Q76340017 description "artículu científicu espublizáu en febreru de 2004" @default.
- Q76340017 description "im Februar 2004 veröffentlichter wissenschaftlicher Artikel" @default.
- Q76340017 description "scientific article published on 16 February 2004" @default.
- Q76340017 description "wetenschappelijk artikel" @default.
- Q76340017 description "наукова стаття, опублікована в лютому 2004" @default.
- Q76340017 name "Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin" @default.
- Q76340017 name "Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin" @default.
- Q76340017 type Item @default.
- Q76340017 label "Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin" @default.
- Q76340017 label "Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin" @default.
- Q76340017 prefLabel "Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin" @default.
- Q76340017 prefLabel "Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin" @default.
- Q76340017 P1433 Q76340017-8B37DF41-A352-4DC3-BC66-46F192F56F88 @default.
- Q76340017 P1476 Q76340017-4804F268-3FAF-4CD8-B3A6-91E155459AD7 @default.
- Q76340017 P2093 Q76340017-0E415873-4023-4592-A2BB-9757251463D2 @default.
- Q76340017 P2093 Q76340017-1900A06E-36A9-454A-9A80-56C4546D46F3 @default.
- Q76340017 P2093 Q76340017-4BF8F2FA-295D-42C2-BA39-EEB606B55441 @default.
- Q76340017 P2093 Q76340017-5586A06D-19D8-45C6-93A0-2EE904C5ECC2 @default.
- Q76340017 P2093 Q76340017-59AAFD7A-DC97-4A93-B7E2-99CF3EB0A129 @default.
- Q76340017 P2093 Q76340017-7913490A-C1D7-4148-89B3-C1B63E9ECB26 @default.
- Q76340017 P2093 Q76340017-8DD6F33C-E474-45E0-8C6C-312287875DFC @default.
- Q76340017 P2093 Q76340017-92D1921F-D31E-47A4-BDFB-6BB5E5DA9022 @default.
- Q76340017 P2093 Q76340017-AC0708A6-4F91-4D09-A4E2-4DBA998344B0 @default.
- Q76340017 P2093 Q76340017-B443E728-943C-4FF0-B89B-7B33195B24E6 @default.
- Q76340017 P2093 Q76340017-E50D8056-1914-428D-9C56-AD1312BD8CBC @default.
- Q76340017 P2093 Q76340017-E7A7ABAB-E524-4AF8-992C-EB33EAF8FD49 @default.
- Q76340017 P304 Q76340017-3C1DCDFA-AB89-45CD-81C9-F0042314EE56 @default.
- Q76340017 P31 Q76340017-2388D409-FC94-4D20-9CC6-1DC620D21B17 @default.
- Q76340017 P356 Q76340017-9C0FBC0F-F6BD-4C87-8598-9504D3EF0EB4 @default.
- Q76340017 P433 Q76340017-0B1D29ED-9E7F-4354-8F5B-24DC4048EA86 @default.
- Q76340017 P478 Q76340017-D846F00A-6ED9-448D-9A11-1B475D1D4C5D @default.
- Q76340017 P577 Q76340017-DAE43895-DBE7-441E-A1B0-2A754BF755DD @default.
- Q76340017 P698 Q76340017-F72BC2F3-9899-4372-9263-3F007FB6C12C @default.
- Q76340017 P921 Q76340017-3F355BB0-3E4E-4BA3-8099-28A07A14B324 @default.
- Q76340017 P921 Q76340017-643674E3-B45A-4577-BF67-35B4CE0579E2 @default.
- Q76340017 P921 Q76340017-B30653D1-7358-4214-9932-932841A2047D @default.
- Q76340017 P921 Q76340017-EF88E624-32FC-400E-8059-AD6460898599 @default.
- Q76340017 P356 01.CIR.0000120509.64740.DC @default.
- Q76340017 P698 14967716 @default.
- Q76340017 P1433 Q578091 @default.
- Q76340017 P1476 "Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial" @default.
- Q76340017 P2093 "ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group" @default.
- Q76340017 P2093 "Andreas Mügge" @default.
- Q76340017 P2093 "Caroline Schmidt-Lucke" @default.
- Q76340017 P2093 "Christoph Geller" @default.
- Q76340017 P2093 "Christoph Stellbrink" @default.
- Q76340017 P2093 "Jan-André Schmidt-Lucke" @default.
- Q76340017 P2093 "Peter Hanrath" @default.
- Q76340017 P2093 "Thomas Hofmann" @default.
- Q76340017 P2093 "Uwe Nixdorff" @default.
- Q76340017 P2093 "Walter Lehmacher" @default.
- Q76340017 P2093 "Walter Sehnert" @default.
- Q76340017 P2093 "Werner Günther Daniel" @default.
- Q76340017 P304 "997-1003" @default.
- Q76340017 P31 Q13442814 @default.
- Q76340017 P356 "10.1161/01.CIR.0000120509.64740.DC" @default.
- Q76340017 P433 "8" @default.
- Q76340017 P478 "109" @default.
- Q76340017 P577 "2004-02-16T00:00:00Z" @default.
- Q76340017 P698 "14967716" @default.
- Q76340017 P921 Q1729126 @default.
- Q76340017 P921 Q190016 @default.
- Q76340017 P921 Q63279445 @default.
- Q76340017 P921 Q815819 @default.